NASDAQ: LFCR
Lifecore Biomedical Inc Stock Ownership - Who owns Lifecore Biomedical?

Insider buying vs selling

Have Lifecore Biomedical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul JosephsChief Executive Officer2026-05-2040,413$4.57
$184.69kSell
Thomas D. SalusChief Legal Administration2026-04-1424,645$5.20
$128.15kSell

1 of 1

LFCR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LFCR insiders and whales buy or sell their stock.

LFCR Shareholders

What type of owners hold Lifecore Biomedical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Nelson Obus22.79%8,627,100$54.95MInsider
Wynnefield Partners Small Cap Value LP I12.42%4,703,216$29.96MInsider
Christopher S. Kiper11.91%4,507,236$28.71MInsider
Kenneth E. 1. Jones3.74%1,417,456$9.03MInsider
Gregory S. Skinner2.37%896,183$5.71MInsider
Paul Josephs1.57%592,915$3.78MInsider
David D. Taft1.27%480,150$3.06MInsider
Fred Frank1.09%413,282$2.63MInsider
Gary T. Steele1.02%385,376$2.45MInsider
Ryan David Lake0.89%336,691$2.14MInsider

1 of 3

LFCR vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LFCR0.07%68.29%Net Selling
ACB0.01%0.00%
BIOA0.08%21.56%Net Selling
SIGA0.05%86.77%Net Selling
CGC0.01%25.96%Net SellingNet Selling

Lifecore Biomedical Stock Ownership FAQ

Who owns Lifecore Biomedical?

Lifecore Biomedical (NASDAQ: LFCR) is owned by 0.07% institutional shareholders, 68.29% Lifecore Biomedical insiders, and 31.65% retail investors. Nelson Obus is the largest individual Lifecore Biomedical shareholder, owning 8.63M shares representing 22.79% of the company. Nelson Obus's Lifecore Biomedical shares are currently valued at $55.21M.

If you're new to stock investing, here's how to buy Lifecore Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.